LYNN MEHLER, Partner, Hogan Lovells

Lynn Whipkey Mehler is a partner in Hogan Lovell’s Washington, DC office.  She is the head of the firm’s Pharmaceuticals and Biotechnology regulatory practice and Co-Head of the global Life Sciences & Health Care industry sector.  Drawing on her 12 years with the FDA's Office of the Chief Counsel, Lynn has a deep understanding of the FDA and advises clients on a range of FDA and DEA regulatory matters.  She has worked extensively on the approval processes for new drugs and biologics; on safety issues, including pharmacovigilance and  Risk Evaluation and Mitigation Strategies (REMS),  and on unique regulatory issues raised during the development and marketing of controlled substances.